Stavros G. Vizirgianakis Receives Stock Award at Xtant Medical Holdings Inc (XTNT) — SEC Form 4, Aug 18, 2026
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Equity Position
7.84M sh
7,515,570 → 7,838,845
Equity Change
+4.3%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Stavros G. Vizirgianakis CIK 0001559834 |
Director
|
Stavros G. Vizirgianakis at Xtant Medical Holdings Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Xtant Medical Holdings Inc
| 2025-11-18 | Award | — | View |
| 2024-08-19 | Award | — | View |
| 2023-08-17 | Award | — | View |
| 2022-11-17 | Award | — | View |
| 2022-10-11 | Buy | +$1,087,133 | View |
Non-Derivative Securities Transactions
Footnotes (2)
- F1
- These shares are subject to a deferred stock unit (DSU) award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan and will vest on August 15, 2027, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date. The settlement of the vested shares underlying the DSU award has been deferred and will occur at a later date pursuant to the terms of the DSU award agreement. Each DSU represents a contingent right to receive one share of the Issuer's common stock. Show more
- F2
- Includes 1,843,491 shares issuable upon settlement of DSUs granted under the Xtant Medial Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining a director of Xtant through the respective vesting date. Show more
Related filings at Xtant Medical Holdings Inc
Institutional Holders
13F holders · Jun 30, 2026
31
institutional managers reporting a position
Largest by reported value
5%+ Holders · 13D/G
2 filers
Other insiders at Xtant Medical Holdings Inc
GET /v1/forms/4/0001559834-26-000001
API docs
View Original SEC Filing